Ephrin type-A receptor 2 (EPHA2) is a receptor tyrosine kinase (RTK), the overexpression of EPHA2 is associated with metastasis in a variety of cancers, including melanomas and ovarian, prostate, lung, and breast cancers. Here, EPHA2 is linked to melanoma.